We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Share News (PRTC)

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 212.50
Bid: 211.50
Ask: 213.50
Change: -0.50 (-0.23%)
Spread: 2.00 (0.946%)
Open: 213.00
High: 214.00
Low: 209.00
Prev. Close: 213.00
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Angus in Balcombe blow; YouGov buys Canada asset

Tue, 02nd Mar 2021 19:11

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Angus Energy PLC - UK-focused onshore oil and gas development company - Notes West Sussex County Council's Planning Committee rejects planning application for an extended well test at Balcombe oil field. Angus says "disappointed" by decision. "The company is presently evaluating all of the options available with its partners," Angus adds.

----------

YouGov PLC - London-based research data and analytics group - Buys Toronto-based sports research and consulting agency Charlton Insights, boosting YouGov Sport's presence in Canada. Acquisition fee is tied to a "three year earn-out", YouGov adds.

----------

CloudCall Group PLC - Leicester, England-based provider of unified communications and contact centre software - Receives additional demand so boosts size of fundraising to GBP7.5 million, from GBP7.0 million. Equity raise consists of 8.8 million placing shares and 357,169 shares as part of PrimaryBid offer.

----------

Next Fifteen Communications Group PLC - London-based digital communication group - To repay GBP1.4 million in furlough money from UK government amid "continued strong trading performance".

----------

FastForward Innovations Ltd - technology and life sciences sector focused investor - Notes 2.3% owned investee EMMAC Life Sciences sells wellness brands to Yooma Wellness Inc. FastForward has a 9.0% stake in Yooma.

----------

Vela Technologies PLC - Bingley, England-based company with investments in early-stage disruptive technology businesses - Invests roughly GBP66,000 in Mode Global Holdings PLC, as part of the London-listed fintech firm's GBP6 million placing.

----------

Warehouse REIT PLC - real estate investment trust focused on warehouse assets - Buys multi-let warehouse estate on Glasgow Airport Business Park for GBP5.3 million, representing net initial yield of 6.3%. "The property generates a net rental income of GBP357,000 per annum," Warehouse REIT adds.

----------

600 Group PLC - West Yorkshire, England-based manufacturer and distributor of machine tools, precision engineered components and industrial laser systems - Says three US operations granted forgiveness of initial loans under US government's Paycheck Protection Program. Loans amount to USD2.2 million. "Second round funding under the PPP scheme for an additional USD2.2 million has been applied for. From this application, two of the three entities have so far received their allocation, amounting to USD1.6 million, with the remaining USD600,000 expected to be received in the coming weeks," 600 adds. Notes order intake has continued to improve since first Covid-19 outbreak, with February up about 40% annually.

----------

Coral Products PLC - Merseyside-based supplier of injection moulded plastic products - Completes disposal of Coral Product (Mouldings) Ltd and Interpack Ltd to One51 ES Plastics UK Ltd for GBP7.9 million. Notes as planned, Chief Executive Officer Michael Wood steps down following disposals. Non-Executive Chair Joseph Grimmond becomes executive chair.

----------

Omega Diagnostics Group PLC - sells wide range of specialist products, primarily in the immunoassay, in-vitro diagnostics market - Lands contract with Screen4 Ltd to provide Covid-19 antibody laboratory-based testing services.

----------

Quadrise Fuels International PLC - London-based fuel conversion technology firm - Raises GBP6.0 million from placing of 222.2 million shares at 2.7 pence each.

----------

PureTech Health PLC- Boston, Massachusetts-based biotherapeutics company - Founded entity Karuna Therapeutics, a firm developing medicines for psychiatric and neurological conditions, prices offer of 2.1 million shares at USD120.00 each. To raise about USD250.0 million.

----------

Castillo Copper Ltd - Australia and Zambia focused base metal explorer - Earmarks "strategic intent" to progress Big One deposit, Australia following " a series of excellent assay results" and global demand for copper. Castillo adds: "Further work is planned to extend known mineralisation and Big One deposit's potential scale, commencing with an induced polarisation survey to identify incremental test-drill targets."

----------

88 Energy Ltd - Alaska-focused oil producer - Says mobilisation of rig 111 to Merlin-1 location "progressing well" but reports "minor delays" attributed to weather. Spud date scheduled for March 8.

----------

Serabi Gold PLC - Brazil-focused gold miner - Raises USD17.5 million, about GBP12.5 million, from placing of 16.7 million shares at GBP0.75 each. "The financing completed today creates a strong financial position for Serabi from which we will be able to advance our significant growth opportunities," CEO Mike Hodgson says.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
18 Apr 2024 14:17

UK earnings, trading statements calendar - next 7 days

Friday 19 April 
888 Holdings PLCTrading Statement
Man Group PLCTrading Statement
Monday 22 April 
Brave Bison Group PLCFull Year Results
Elixirr International PLCFull Year Results
Frenkel Topping Group PLCFull Year Results
Mobico Group PLCFull Year Results
South32 LtdQ3 Results
Ten Lifestyle Group PLCHalf Year Results
Tuesday 23 April 
Alliance Pharma PLCFull Year Results
Alphawave IP Group PLCFull Year Results
Anglo American PLCTrading Statement
ASA International Group PLCFull Year Results
Associated British Foods PLCHalf Year Results
Eleco PLCFull Year Results
GB Group PLCTrading Statement
Jupiter Fund Management PLCTrading Statement
Maintel Holdings PLCFull Year Results
Property Franchise Group PLCFull Year Results
Taylor Wimpey PLCTrading Statement
tinyBuild IncFull Year Results
Trellus Health PLCFull Year Results
Wednesday 24 April 
1Spatial PLCFull Year Results
abrdn PLCTrading Statement
Ecora Resources PLCTrading Statement
Fresnillo PLCTrading Statement
Lloyds Banking Group PLCQ1 Results
Nichols PLCTrading Statement
PensionBee Group PLCFirst Quarter Results
PZ Cussons PLCTrading Statement
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Serica Energy PLCFull Year Results
Star Energy Group PLCFull Year Results
Tortilla Mexican Grill PLCFull Year Results
Tracsis PLCHalf Year Results
Warpaint London PLCFull Year Results
Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Hikma Pharmaceuticals PLCTrading Statement
Focusrite PLCHalf Year Results
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
16 Apr 2024 21:57

EARNINGS AND TRADING: J Smart boosts revenue, Tertiary starts drilling

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
11 Apr 2024 13:01

US FDA hands fast track to PureTech head and neck cancer treatment

(Alliance News) - PureTech Health PLC on Thursday said that its LYT-200 cancer treatment has received a significant endorsement from the US drugs regulator.

Read more
9 Apr 2024 11:33

PureTech Health CEO Zohar moves to head-up portfolio firm Seaport

(Alliance News) - PureTech Health PLC on Tuesday said its founding chief executive officer, Daphne Zohar, will shift to become CEO of Seaport Therapeutics, a biopharmaceutical company founded by PureTech.

Read more
9 Apr 2024 07:48

PureTech founder steps down as CEO to lead SeaPort spin-off

(Sharecast News) - Clinical-stage biotherapeutics group PureTech has announced that its founding chief executive is to step down to lead SeaPort Therapeutics, a PureTech company she founded that has just raised $100m in Series A financing.

Read more
19 Mar 2024 16:57

LONDON MARKET CLOSE: European large-caps rise on eve of Fed decision

(Alliance News) - Blue-chip stock prices in Europe closed higher on Tuesday, showing little signs of nerves ahead of Wednesday's Federal Reserve decision and UK inflation reading.

Read more
19 Mar 2024 11:16

PureTech shares jump on USD100 million tender offer proposal

(Alliance News) - PureTech Health PLC on Tuesday said it plans to return USD100 million to shareholders with a tender offer, starting after it publishes its annual report in April.

Read more
19 Mar 2024 09:46

Puretech Health proposes $100m capital return

(Sharecast News) - Biotherapeutics company PureTech Health has proposed a capital return of $100.0m to its shareholders by way of a tender offer.

Read more
13 Mar 2024 12:27

PureTech Health celebrates drug designation for LYT-200 from US FDA

(Alliance News) - PureTech Health PLC on Wednesday touted the efficacy of its acute myeloid leukaemia therapy, after securing a regulatory designation from the US Food & Drug Administration.

Read more
27 Feb 2024 11:28

PureTech notes positive results from Shionogi's EndeavorRx ADHD trial

(Alliance News) - PureTech Health PLC on Tuesday noted that its founded entity, Akili Inc, has announced positive results from a phase 3 clinical trial of EndeavorRx for children with attention deficit hyperactivity disorder in Japan.

Read more
20 Dec 2023 09:53

PureTech makes strong progress, expects "multiple catalysts" next year

(Alliance News) - PureTech Health PLC on Wednesday said it made "strong strategic and clinical progress" in 2023, and predicted "a productive and exciting" tear to come.

Read more
1 Dec 2023 14:29

TRADING UPDATES: N4 launches investor hub; Capricorn production falls

(Alliance News) - The following is a round-up of trading updates by London-listed companies, issued on Wednesday, Thursday and Friday and not separately reported by Alliance News:

Read more
17 Nov 2023 09:44

IN BRIEF: PureTech hails schizophrenia trial results for Karuna drug

PureTech Health PLC - Boston, Massachusetts-based FTSE 250 biotechnology company - Founded entity Karuna Therapeutics reports "positive results" from Phase 1b trial evaluating the effects of xanomeline-trospium, brand name KarXT, on 24-hour ambulatory blood pressure in adults with schizophrenia. Karuna says KarXT does not cause clinically meaningful blood pressure increases, with an average change from baseline at week eight of minus 0.59 mmHg or millimetre of mercury. Other vital signs like average diastolic blood pressure and heart rate were consistent with previous KarXT trials in schizophrenia. Adds that KarXT was generally well-tolerated, and side effects remained consistent with prior trials under the Emergent programme. Karuna in late September announced its application to the US Food & Drug Administration for approval of KarXT to treat schizophrenia; if successful, it will be PureTech's third therapeutic candidate to gain FDA approval. KarXT is also in development to treat psychosis associated with Alzheimer's disease.

Read more
17 Nov 2023 07:58

LONDON BRIEFING: UK retail sales fall; AstraZeneca gets US approval

(Alliance News) - Stock prices in London are still set to open higher on Friday, despite October retail sales figures for the UK disappointing shortly before the opening bell.

Read more
14 Nov 2023 10:59

PureTech Health celebrates positive results in Phase 2 anxiety trial

(Alliance News) - PureTech Health PLC on Tuesday said its therapeutic LYT-300 achieved its primary endpoint for acute anxiety reduction, in a Phase 2a trial using healthy volunteers.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.